Bill

Bill > SB12


KY SB12

AN ACT relating to prescription drugs.


summary

Introduced
01/07/2025
In Committee
01/09/2025
Crossed Over
Passed
Dead
03/28/2025

Introduced Session

2025 Regular Session

Bill Summary

Amend KRS 304.17A-164 to define terms; establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with prescription drug cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; amend KRS 304.17C-125, 304.38A-115, 18A.225, and 164.2871 to apply the cost-sharing and rebate requirements for prescription drugs to limited health service benefit plans, limited health service organizations, the state employee health plan, and self-insured employer group health plans provided by the governing board of a state postsecondary education institution; apply provisions to health plans issued or renewed on or after January 1, 2026; EFFECTIVE January 1, 2026.

AI Summary

This bill amends Kentucky law to establish new requirements for prescription drug cost-sharing and rebates in health insurance plans. The bill defines key terms like "rebate" and "cost sharing" and mandates that at least 85% of rebates received by insurers or pharmacy benefit managers must be passed through to consumers by reducing their out-of-pocket costs at the point of sale. Any remaining rebates must be used to lower health plan premiums. The legislation also includes strict confidentiality provisions, treating rebate information as a trade secret that cannot be publicly disclosed in a way that could identify specific products, manufacturers, or financial details. The new requirements will apply to various types of health plans, including limited health service benefit plans, state employee health plans, and self-insured employer group health plans provided by state postsecondary education institutions. These provisions will take effect for health plans issued or renewed on or after January 1, 2026, with the goal of making prescription drugs more affordable for consumers by ensuring that negotiated price concessions and rebates directly benefit patients.

Committee Categories

Business and Industry

Sponsors (3)

Last Action

to Banking & Insurance (S) (on 01/09/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...